Low-density lipoprotein cholesterol lowering treatment: the current approach
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-density lipoprotein cholesterol lowering treatment: the current approach
Authors
Keywords
-
Journal
Lipids in Health and Disease
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-06
DOI
10.1186/s12944-020-01275-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics
- (2020) Mădălina Ioana Moisi et al. Medicina-Lithuania
- The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
- (2019) Jean-Charles Fruchart et al. Cardiovascular Diabetology
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease
- (2019) Anne C. Goldberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk
- (2018) Steve Yadlowsky et al. ANNALS OF INTERNAL MEDICINE
- PCSK9 inhibitors in clinical practice: Expectations and reality
- (2018) Željko Reiner ATHEROSCLEROSIS
- Bempedoic Acid (ETC-1002)
- (2018) Anum Saeed et al. CARDIOLOGY CLINICS
- New hope for hyperlipidemia management: Inclisiran
- (2018) Dhrubajyoti Bandyopadhyay et al. Journal of Cardiology
- Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease
- (2018) Peter P. Toth et al. KIDNEY INTERNATIONAL
- 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
- (2017) Ulf Landmesser et al. EUROPEAN HEART JOURNAL
- Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab
- (2017) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Hypertriglyceridaemia and risk of coronary artery disease
- (2017) Željko Reiner Nature Reviews Cardiology
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome
- (2016) Eliano P. Navarese et al. ANNALS OF INTERNAL MEDICINE
- Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention
- (2016) Martin Bødtker Mortensen et al. EUROPEAN HEART JOURNAL
- A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy
- (2015) Carlos Aguiar et al. ATHEROSCLEROSIS SUPPLEMENTS
- Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
- (2014) D. Keene et al. BMJ-British Medical Journal
- Statins and Cognitive Function
- (2013) Karl Richardson et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety evaluation of intensive statin therapy in older patients with coronary heart disease: a systematic review and meta-analysis
- (2013) Y. L. Yan et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease
- (2013) Gianluigi Savarese et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins in the primary prevention of cardiovascular disease
- (2013) Željko Reiner Nature Reviews Cardiology
- The Effect of HMG-CoA Reductase Inhibitors on Cognition in Patients With Alzheimer's Dementia: A Prospective Withdrawal and Rechallenge Pilot Study
- (2012) Kalpana P. Padala et al. American Journal Geriatric Pharmacotherapy
- How to control residual cardiovascular risk despite statin treatment: Focusing on HDL–cholesterol
- (2012) Soo Lim et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
- (2012) Evan A. Stein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
- (2011) Allan D. Sniderman et al.
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- Dyslipidemia in renal disease: Causes, consequences and treatment
- (2010) Joana Mesquita et al. Endocrinologia y Nutricion
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
- (2008) Jean-Charles Fruchart et al. Diabetes & Vascular Disease Research
- Systemic lupus erythematosus and “lupus dyslipoproteinemia”
- (2007) Jozélio Freire de Carvalho et al. AUTOIMMUNITY REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now